Girls in the first birth cohort to be offered and receive the HPV vaccine showed a lower degree of dysplasia which may eventually lead to cervical cancer than a birth cohort from 1983. This is the conclusion of a new study conducted by researchers at the University of Copenhagen, who have been the first to study the vaccine’s effect on the general population.Watch Now
More than two dozen ADCs are currently being used in the clinic to treat diseases like Hodgkin's lymphoma and breast cancer, and researchers are developing many more. But it's taken decades to find the right combination of drug, antibody target and linker, and then make sure the right amount of ADC hits the tumor.
Near-infrared photoimmunotherapy uses an antibody–photoabsorber conjugate that binds to cancer cells. When near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die.Watch Now
In January 2016 a number of countries in South East Europe started vaccinating cattle against lumpy skin disease. As the programme has progressed the number of outbreaks has fallen and by the end of 2017 the outbreaks had been contained.Watch Now
This is the first in a three-part series of animations about therapeutic antibodies, providing viewers with an overview of antibody structure and function. The other two videos, will cover antibody 'mechanism of action' and antibody-drug conjugatesWatch Now
Traditionally, cancer treatment has revolved around chemotherapy, radiation and surgery. But thanks to groundbreaking immune checkpoint blockade research led by Jim Allison, Ph.D., we have a new way to treat cancer: immunotherapy. Rather than treating the cancer directly, immunotherapy trains the immune system to attack cancer.Watch Now